Does Farxiga Cause Yeast Infections?
Yes, Farxiga (dapagliflozin), an SGLT2 inhibitor for type 2 diabetes, heart failure, and chronic kidney disease, increases the risk of genital yeast infections. This happens because it raises glucose levels in urine, creating an environment for yeast like Candida to grow.[1][2]
How Common Are Yeast Infections on Farxiga?
In clinical trials, genital mycotic infections occurred in 6-10% of women and 1-2% of men taking Farxiga, compared to lower rates on placebo. Most cases are mild and resolve with antifungal treatment.[1][3]
Why Does Farxiga Specifically Raise This Risk?
Farxiga blocks kidney glucose reabsorption, leading to more sugar in urine and on genital skin. Women face higher rates due to anatomy and estrogen effects on vaginal flora.[2][4]
What Do Patients Report About Yeast Infections?
Users often describe itching, burning, discharge, or redness in genital areas, sometimes recurring during treatment. Over-the-counter antifungals like fluconazole help, but doctors may recommend hygiene tips or dose adjustments.[3][5]
How Does Farxiga Compare to Other SGLT2 Inhibitors?
Similar risks apply to Jardiance (empagliflozin) and Invokana (canagliflozin), with comparable infection rates in head-to-head trials. All carry FDA warnings for genital infections.[1][4]
Can You Prevent Yeast Infections While on Farxiga?
Keep genital areas dry and clean, wear cotton underwear, avoid tight clothes, and control blood sugar. Probiotics or topical antifungals prevent recurrences in some cases—discuss with a doctor.[2][5]
When Should You See a Doctor?
Seek care for severe symptoms, fever, or non-resolving infections, as rare complications like Fournier's gangrene have FDA warnings linked to SGLT2 inhibitors.[1][3]
[1]: FDA Farxiga Label
[2]: Drugs.com Farxiga Side Effects
[3]: Mayo Clinic Dapagliflozin
[4]: NEJM SGLT2 Inhibitor Review
[5]: WebMD Farxiga